Search clinical trials for: Relapsed or Refractory Multiple Myeloma
Total 214989 results
-
European Myeloma NetworkUniversity of Turin, ItalyCompleted
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell University; State University of New York -... and other collaboratorsActive, not recruiting
-
Fondazione EMN Italy OnlusCompleted
-
Fondazione EMN Italy OnlusActive, not recruitingMultiple Myeloma | Deletion 17P SyndromeItaly
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedMultiple MyelomaUnited States, New Zealand
-
Regeneron PharmaceuticalsAvailable
-
Lava TherapeuticsActive, not recruitingAcute Myeloid Leukemia | Multiple Myeloma | Chronic Lymphocytic LeukemiaUnited States, Spain, France, Netherlands
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); European Organisation for Research and Treatment... and other collaboratorsCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States, Canada
-
Nanjing Legend Biotech Co.Ruijin Hospital; Second Affiliated Hospital of Xi'an Jiaotong University; Shanghai... and other collaboratorsActive, not recruitingRefractory or Relapsed Multiple Myeloma
-
Bristol-Myers SquibbCompleted
-
Oncopeptides ABTerminatedRelapsed Multiple Myeloma | Relapsed-Refractory Multiple MyelomaSerbia, Greece, Russian Federation, Czechia, Bulgaria, Georgia, Norway, Poland, Spain, Ukraine, Germany
-
CelgeneCompletedMultiple MyelomaUnited States, Spain, United Kingdom, Italy, Israel, Portugal, Germany, Turkey, Greece, Ireland, Austria, Norway, Netherlands, Denmark, Poland, France, Russian Federation, Canada, Finland, Japan, Puerto Rico, Sweden
-
Intergroupe Francophone du MyelomeBristol-Myers Squibb; Takeda; University Hospital, Grenoble; Nantes University... and other collaboratorsTerminatedMultiple Myeloma | Genetic Condition | Relapsed and Refractory Multiple MyelomaFrance
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Canada, Japan, Puerto Rico
-
Janssen Pharmaceutical K.K.Completed
-
Sorrento Therapeutics, Inc.Active, not recruitingMultiple MyelomaUnited States
-
AmgenTerminatedAcute Myeloid Leukemia | Multiple Myeloma | AML | Myelodysplastic Syndrome | MDS | Non-Hodgkins Lymphoma | NHLUnited States, Australia, Italy, France, Greece, Japan
-
AbbVieGenentech, Inc.CompletedRelapsed/Refractory Multiple MyelomaUnited States, Belgium, France, Norway
-
Genentech, Inc.TerminatedMultiple Myeloma | Non-Hodgkin Lymphoma | B-Cell LymphomaUnited States, Korea, Republic of
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedMultiple MyelomaUnited States, France
-
Incyte CorporationTerminatedRelapsed or Refractory Multiple MyelomaUnited States, Spain, Germany
-
TakedaCompletedRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States, Canada
-
AbbVieTerminatedMultiple MyelomaUnited States, Australia, France, Germany, Israel, Japan, Spain
-
CASI Pharmaceuticals, Inc.Active, not recruitingMultiple MyelomaUnited Kingdom, France
-
Juno Therapeutics, a Subsidiary of CelgeneActive, not recruiting
-
Hoffmann-La RocheCompletedMultiple MyelomaSpain, Denmark, Netherlands, Sweden, Poland, France, Germany, Czechia, Norway
-
Millennium Pharmaceuticals, Inc.Completed
-
Cellectar Biosciences, Inc.CompletedMultiple MyelomaUnited States
-
CelgeneTerminatedMultiple MyelomaUnited States, Canada, Spain, Italy, Denmark, United Kingdom, Belgium, Sweden, Germany
-
Ohio State University Comprehensive Cancer CenterCureTech LtdTerminatedMultiple MyelomaUnited States
-
Alliance Foundation Trials, LLC.Celgene; Janssen, LPWithdrawnRelapsed or Refractory Multiple Myeloma
-
Karyopharm Therapeutics IncActive, not recruitingMultiple MyelomaUnited States, United Kingdom, Australia, Israel, Canada, Belgium, Austria, Czechia, Serbia, India, France, Italy, Russian Federation, Bulgaria, Germany, Greece, Hungary, Poland, Romania, Spain, Ukraine
-
Karyopharm Therapeutics IncWithdrawn
-
Poitiers University HospitalSanofi; Celgene; Amgen; Intergroupe Francophone du MyelomeActive, not recruitingMultiple Myeloma in Relapse | Multiple Myeloma, RefractoryFrance
-
H. Lee Moffitt Cancer Center and Research InstituteKaryopharm Therapeutics IncCompletedMultiple MyelomaUnited States
-
Millennium Pharmaceuticals, Inc.CompletedRelapsed and/or Refractory Multiple MyelomaUnited States, France, Norway, Spain, Israel, United Kingdom, Italy, Australia, Germany, Greece, Canada, Czechia, Turkey, Russian Federation, Denmark, Sweden, Belgium, Netherlands
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Belgium, Canada, France, Germany, Italy, Japan, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom
-
Genentech, Inc.Seagen Inc.Completed
-
AmgenCompletedRelapsed or Refractory Multiple MyelomaUnited States, Belgium, Australia, Spain, Canada, Netherlands
-
Janssen Research & Development, LLCCompleted
-
Oncopeptides ABPrecision For MedicineCompletedMultiple MyelomaSpain, United States, France, Italy
-
Weill Medical College of Cornell UniversityKaryopharm Therapeutics IncWithdrawnAL Amyloidosis | Amyloidosis | AmyloidUnited States
-
Janssen Research & Development, LLCApproved for marketingRelapsed or Refractory Multiple Myeloma
-
ChimerixActive, not recruiting
-
Bristol-Myers SquibbAbbVie; CelgeneCompletedMultiple MyelomaUnited States, Germany, Italy, Greece, Netherlands, Australia, Spain, Poland, Canada, France, Japan
-
CelgeneCompletedMultiple MyelomaBelgium, United Kingdom, Italy, Germany, Sweden, Denmark, Norway, Spain
-
AmgenWithdrawnRelapsed/Refractory Multiple Myeloma
-
TakedaCompleted
-
AmgenCompletedMultiple MyelomaCanada, Denmark, Finland, France, Italy, Spain, Sweden, United Kingdom, Czechia, Poland, United States, Belgium, Hungary, New Zealand, Australia, Germany, Japan, Greece, Norway, Romania